GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alpha Tau Medical Ltd (NAS:DRTS) » Definitions » EV-to-FCF

Alpha Tau Medical (Alpha Tau Medical) EV-to-FCF : (As of May. 06, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Alpha Tau Medical EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Alpha Tau Medical's Enterprise Value is $104.97 Mil. Alpha Tau Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil. Therefore, Alpha Tau Medical's EV-to-FCF for today is .

The historical rank and industry rank for Alpha Tau Medical's EV-to-FCF or its related term are showing as below:

DRTS' s EV-to-FCF Range Over the Past 10 Years
Min: -107.75   Med: 0   Max: 0
Current: -4.31

DRTS's EV-to-FCF is ranked worse than
100% of 382 companies
in the Biotechnology industry
Industry Median: 5.84 vs DRTS: -4.31

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-06), Alpha Tau Medical's stock price is $2.45. Alpha Tau Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.420. Therefore, Alpha Tau Medical's PE Ratio for today is At Loss.


Alpha Tau Medical EV-to-FCF Historical Data

The historical data trend for Alpha Tau Medical's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpha Tau Medical EV-to-FCF Chart

Alpha Tau Medical Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
- - - -4.86 -5.80

Alpha Tau Medical Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.86 -11.58 - - -5.80

Competitive Comparison of Alpha Tau Medical's EV-to-FCF

For the Biotechnology subindustry, Alpha Tau Medical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpha Tau Medical's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alpha Tau Medical's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Alpha Tau Medical's EV-to-FCF falls into.



Alpha Tau Medical EV-to-FCF Calculation

Alpha Tau Medical's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=104.968/0
=

Alpha Tau Medical's current Enterprise Value is $104.97 Mil.
Alpha Tau Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alpha Tau Medical  (NAS:DRTS) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Alpha Tau Medical's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2.45/-0.420
=At Loss

Alpha Tau Medical's share price for today is $2.45.
Alpha Tau Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.420.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Alpha Tau Medical EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Alpha Tau Medical's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Alpha Tau Medical (Alpha Tau Medical) Business Description

Traded in Other Exchanges
N/A
Address
5 Kiryat Hamada Street, Building B3, 4th Floor, Jerusalem, ISR, 9777605
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors.